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Small fiber neuropathy in sarcoidosis: Something
beneath the surfaceUnderwater explorer Jacques Cousteau once said that the
more he dove into the sea, the less he understood it. The
same could be said about our knowledge of sarcoidosis.
Sarcoidosis was originally thought to be a skin disease, as
these lesions were readily visible whereas detection of
visceral sarcoidosis required the advent of the roentgeno-
gram to submerge beneath the surface. Thanks in large part
to William Conrad Roentgen’s invention, sarcoidosis was
subsequently understood to be a multiorgan granulomatous
disease of unknown cause. It became apparent that sarcoid
granulomas could deposit anywhere in the body, although
most commonly in the lungs, skin, eyes, and liver.
However, as we descended into deeper waters, it
became obvious that the manifestations of sarcoidosis
could not be explained by granuloma deposition alone.
Sarcoidosis is associated with elevated levels of circulating
immune complexes.1 Anergy is commonly seen.2 Non-
granulomatous inflammatory reactions such as erythema
nodosum may occur.3 These three phenomena, which are
commonly observed with active sarcoidosis, cannot be
easily explained by the granulomatous model. Researchers
have pursued genetic, proteomic, and immunological
approaches to explain these findings. It is assumed that
these sarcoidosis-associated events are related to either
a trigger or a consequence of sarcoid granuloma formation.
The waters became murkier still upon the realization that
several major concerns of sarcoidosis patients include symp-
toms that cannot be explained by granulomatous involvement
of a particular organ. Pain,4 fatigue,5 and depression6 are
common patient complaints that are often debilitating and
adversely affect sarcoidosis patients’ quality of life. These
issues are often troubling to pulmonologists and other sarcoi-
dologists because they do not relate directly to a physiologic
abnormality, areproblematic toquantifyandhence tomonitor,
and are challenging to treat.
Finally, we have reached a depth where the darkness
that envelops us has caused complete disorientation. ThisDOI of original articles: 10.1016/j.rmed.2010.09.015, 10.1016/
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demonstrated that sarcoidosis is associated with a small
fiber neuropathy.7,8 This concept is beyond the event
horizon of both pulmonary medicine and the granuloma.
The mechanism responsible for the development of small
fiber neuropathy in sarcoidosis is unclear. Nevertheless,
small fiber neuropathy may occur in more than one quarter
of all sarcoidosis patients and lead to significant symp-
toms.7 Furthermore, standard sarcoidosis treatments such
as corticosteroids and other immunosuppressive agents are
often ineffective for this neuropathy.
Small fiber neuropathy has been recognized as a specific
entity involving the unmyelinated C and thinlymyelinated Ad
fibers.9 These fibers encompass thermal and nociceptive
sensations and pathology of these nerves may lead to
a “painful neuropathy.”9 However, these nerves additionally
affect the autonomic nervous system, and small fiber
neuropathy may also lead to an “autonomic neuropathy.”9
Defects in small fibers cannot be detected by routine nerve
conduction studies. This may lead to frustration of both the
physician and patient from failure to diagnose a neuropathic
pain syndrome caused by abnormalities in the small fibers.9
There is no gold standard for the diagnosis of small fiber
neuropathy.9 Discordant criteria for the diagnosis include
psychophysical tests (temperature sensation thresholds10),
neurophysiological tests (laser evoked potentials,11 contact
heat evoked potentials,12 and quantitative sudomotor axon
testing e QSART13), and results from skin or nerve biopsies
(intraepidermal nerve fiber quantification14,15).
Two articles published in this issue of Respiratory
Medicine may aid the clinician in the detection and treat-
ment of sarcoidosis associated small fiber neuropathy. The
paper by Hoistsma and colleagues described a screening
instrument for the diagnosis of sarcoidosis associated small
fiber neuropathy, the Small Fiber Neuropathy Screening
List.16 This instrument has actually been previously intro-
duced in a PhD dissertation by the first author17 but never
as a refereed manuscript. This instrument consists of 21
questions and was well constructed to detect sarcoidosis
patients who will have an abnormal temperature threshold.
2 Editorialtest. However, the test is not perfectly accurate in
detecting sarcoidosis associated small fiber neuropathy
since there is no gold standard test for this disorder.
Therefore, even if the Small Fiber Neuropathy Screening
List accurately identified all sarcoidosis patients with
abnormal temperature threshold tests, it may fail to detect
symptomatic patients who have a normal temperature
threshold test but neurophysiologic or biopsy evidence of
the disorder. Nevertheless, I believe that this instrument is
an important first step that provides the clinician with
a rough screening tool for sarcoidosis associated small fiber
neuropathy.
Thearticle byParambil andcoworkers18 describes theuseof
intravenous immunoglobulin for sarcoidosis associated small
fiberneuropathy in threepatients.Thesepatients’neuropathic
symptoms failed to respond to corticosteroids (2 patients),
methotrexate (2 patients), and infliximab (2 patients), even
though the latter agent has been reported to be effective in
a previous case report.19 Intravenous immunoglobulin has been
shown to be effective in previous case series of small fiber
neuropathy related to other inflammatory syndromes.20,21
Clearly, this small case series does not prove that intravenous
immunoglobulin is effective, much less the superior agent for
sarcoidosis associated small fiber neuropathy. However, these
data supply the rationale to consider this therapy when faced
with a sarcoidosis patient with small fiber neuropathy who has
failed standard anti-sarcoidosis treatment.
These two papers provide two small flashlights to survey
an important clinical issue for sarcoidosis patients that
currently remains shrouded in the dark abyss of the
sarcoidosis sea. It will require much more work to shine
a beacon on this problem.
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